480 related articles for article (PubMed ID: 29020488)
1. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
[TBL] [Abstract][Full Text] [Related]
2. Vogt-Koyanagi-Harada syndrome (uveomeningoencephalitic syndrome).
Manethova K; Ernest J; Hrevus M
Eur J Ophthalmol; 2017 Jan; 27(1):e5-e8. PubMed ID: 28009404
[TBL] [Abstract][Full Text] [Related]
3. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
Karacorlu M; Arf Karacorlu S; Ozdemir H
Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
[TBL] [Abstract][Full Text] [Related]
5. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
[TBL] [Abstract][Full Text] [Related]
6. Headache and Bilateral Optic Disc Edema as the Initial Manifestation of Vogt-Koyanagi-Harada Disease.
Nichani P; Christakis PG; Micieli JA
J Neuroophthalmol; 2021 Mar; 41(1):e128-e130. PubMed ID: 32102009
[TBL] [Abstract][Full Text] [Related]
7. Presumed Vogt-Koyanagi-Harada disease with unilateral ocular involvement: report of three cases.
Usui Y; Goto H; Sakai J; Takeuchi M; Usui M; Rao NA
Graefes Arch Clin Exp Ophthalmol; 2009 Aug; 247(8):1127-32. PubMed ID: 19308440
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.
Arevalo JF; Lasave AF; Gupta V; Kozak I; Al Harbi MB; Al Rushood AA; Al Dhibi HA
Ocul Immunol Inflamm; 2016 Oct; 24(5):521-9. PubMed ID: 26399962
[TBL] [Abstract][Full Text] [Related]
9. Unilateral Presentation of Vogt-Koyanagi-Harada Syndrome.
Hosseini SM; Dourandish M; Mazouchi M
J Ophthalmic Vis Res; 2020; 15(1):99-103. PubMed ID: 32128086
[TBL] [Abstract][Full Text] [Related]
10. Development of Acute Vogt-Koyanagi-Harada-like Syndrome during the Treatment Course with Vemurafenib for Metastatic Melanoma.
Apivatthakakul A; Kunavisarut P; Rothova A; Pathanapitoon K
Ocul Immunol Inflamm; 2020 Apr; 28(3):505-508. PubMed ID: 31161956
[No Abstract] [Full Text] [Related]
11. Vogt-Koyanagi-Harada disease developed during chemotherapy for Hodgkin lymphoma: a case report.
Koyama M; Nishijima E; Honda T; Gonmori-Ohta C; Sasamoto T; Tanaka K; Watanabe A; Nakano T; Akiyama M
BMC Ophthalmol; 2024 Mar; 24(1):115. PubMed ID: 38481205
[TBL] [Abstract][Full Text] [Related]
12. Spectral domain optical coherence tomography and autofluorescence in a case of acute posterior multifocal placoid pigment epitheliopathy mimicking Vogt-Koyanagi-Harada disease: case report and review of literature.
Lee GE; Lee BW; Rao NA; Fawzi AA
Ocul Immunol Inflamm; 2011 Feb; 19(1):42-7. PubMed ID: 21034311
[TBL] [Abstract][Full Text] [Related]
13. A case of recalcitrant pediatric Vogt-Koyanagi-Harada disease successfully controlled with adalimumab.
Su E; Oza VS; Latkany P
J Formos Med Assoc; 2019 May; 118(5):945-950. PubMed ID: 30616991
[TBL] [Abstract][Full Text] [Related]
14. Vogt-Koyanagi-Harada disease after stapedotomy.
Accorinti M; Gilardi M; Nardella C; Amorelli GM; Pesci FR
Eur J Ophthalmol; 2015 Oct; 25(6):e127-30. PubMed ID: 25982211
[TBL] [Abstract][Full Text] [Related]
15. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging.
Fukutsu K; Namba K; Iwata D; Mizuuchi K; Kase S; Suzuki K; Shimizu H; Shibata Y; Yamawaki F; Onozawa M; Ishida S
BMC Ophthalmol; 2020 Mar; 20(1):94. PubMed ID: 32156266
[TBL] [Abstract][Full Text] [Related]
16. Long-term Outcomes of Limited Vogt-Koyanagi-Harada Syndrome.
Chew SK; Levy J; Rogers S; Lim LL
Am J Ophthalmol; 2016 Jul; 167():52-6. PubMed ID: 27066721
[TBL] [Abstract][Full Text] [Related]
17. Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; AlBloushi AF; Gikandi PW; Hardarson SH; Stefánsson E
Br J Ophthalmol; 2019 Dec; 103(12):1695-1699. PubMed ID: 30798260
[TBL] [Abstract][Full Text] [Related]
18. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
Lu S; Taban M
Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
[TBL] [Abstract][Full Text] [Related]
19. Autofluorescence findings in Vogt-Koyanagi-Harada disease.
Ayata A; Dogru S; Senol MG; Unal M; Ersanli D; Bilge AH
Eur J Ophthalmol; 2009; 19(6):1094-7. PubMed ID: 19882556
[TBL] [Abstract][Full Text] [Related]
20. Vogt-Koyanagi-Harada disease in a patient of chronic myeloid leukemia.
Chawla R; Meena S; Tomar AS; Venkatesh P; Vohra R
Indian J Ophthalmol; 2017 May; 65(5):411-413. PubMed ID: 28574001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
